Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
figure
posted on 2020-07-29, 08:19 authored by Pietro Lampertico, Stefan Mauss, Marcello Persico, Stephen T. Barclay, Steven Marx, Kristina Lohmann, Mark Bondin, ZhenZhen Zhang, Fiona Marra, Pamela S. Belperio, Heiner Wedemeyer, Steven Flamm<p><strong>Article full text</strong></p><p><br>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).</p><p>© The authors, CC-BY-NC 2020.</p>
History
Related Materials
- 1.
- 2.
